Oneness Biotech Co., Ltd.
4743.TWO
Price:
$58.9
Market Cap:
$28.18B
Oneness Biotech Co., Ltd engages in the research and development of new drugs, and sale of pharmaceutical and health products in Taiwan. It operates through New Drug Research and Development, and Agricultural Products Cultivation segments. The company develops ON101, which is in Phase III clinical trials for treating chronic diabetic foot ulcers; and OB318, an anti-cancer drug that is in Phase I clinical trials. It is also developing FB704A that has completed Phase I clinical trial for the treatment of rheumatoid arthritis and systemic sclerosis; FB825, which is in Phase II clinical trial for treating atopic dermatitis, allergic diseases, and asthma; and FB918, a human monoclonal antibody, w...[Read more]
Industry
Biotechnology
IPO Date
2011-09-23
Stock Exchange
TWO
Ticker
4743.TWO
PE Ratio
[-20.10]
ROE
[-12.52%]
Current Ratio
[37.04]
Dividend Yield
[0%]
Enterprise Value
[26.87B]
Dividend History
The ROE as of December 2025 (TTM) for Oneness Biotech Co., Ltd. (4743.TWO) is -12.52%
According to Oneness Biotech Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -12.52%. This represents a change of 294.32% compared to the average of -3.17% of the last 4 quarters.
Oneness Biotech Co., Ltd. (4743.TWO) Historical ROE (quarterly & annually)
How has 4743.TWO ROE performed in the past?
The mean historical ROE of Oneness Biotech Co., Ltd. over the last ten years is -4.85%. The current -12.52% ROE has changed 158.20% with respect to the historical average. Over the past ten years (40 quarters), 4743.TWO's ROE was at its highest in in the June 2020 quarter at 5.59%. The ROE was at its lowest in in the June 2025 quarter at -8.07%.
Average
-4.85%
Median
-4.28%
Minimum
-11.60%
Maximum
2.46%
Oneness Biotech Co., Ltd. (4743.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of Oneness Biotech Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.07%
Maximum Annual ROE = 2.46%
Minimum Annual Increase = -479.36%
Minimum Annual ROE = -11.60%
| Year | ROE | Change |
|---|---|---|
| 2024 | -9.47% | 1.41% |
| 2023 | -9.34% | -479.36% |
| 2022 | 2.46% | -183.61% |
| 2021 | -2.95% | 59.54% |
| 2020 | -1.85% | -64.44% |
| 2019 | -5.19% | -55.24% |
| 2018 | -11.60% | 75.24% |
| 2017 | -6.62% | 1.07% |
| 2016 | -0.56% | -83.21% |
| 2015 | -3.36% | -132.58% |
Oneness Biotech Co., Ltd. (4743.TWO) Average ROE
How has 4743.TWO ROE performed in the past?
The current ROE of Oneness Biotech Co., Ltd. (4743.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-5.45%
5-year avg
-4.23%
10-year avg
-4.85%
Oneness Biotech Co., Ltd. (4743.TWO) ROE vs. Peers
How is 4743.TWO’s ROE compared to its peers?
Oneness Biotech Co., Ltd.’s ROE is greater than Lumosa Therapeutics Co., Ltd. (-25.00%), greater than Polaris Group (-56.89%), greater than Lin BioScience, Inc. (-24.96%), greater than EirGenix Inc. (-8.06%), greater than Pell Bio-Med Technology Co., Ltd. (-34.78%), greater than Tanvex BioPharma, Inc. (-31.36%), greater than TaiMed Biologics Inc. (-5.54%), less than Sunmax Biotechnology Co., Ltd. (54.00%), greater than Caliway Biopharmaceuticals Co., Ltd. (-5.14%), greater than AP Biosciences Inc (-25.56%),
| Company | ROE | Market cap |
|---|---|---|
| -25.00% | $31.61B | |
| -56.89% | $24.00B | |
| -24.96% | $33.05B | |
| -8.06% | $19.18B | |
| -34.78% | $20.77B | |
| -31.36% | $16.23B | |
| -5.54% | $17.02B | |
| 54.00% | $21.57B | |
| -5.14% | $24.93B | |
| -25.56% | $13.62B |
Build a custom stock screener for Oneness Biotech Co., Ltd. (4743.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oneness Biotech Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Oneness Biotech Co., Ltd. (4743.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Oneness Biotech Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Oneness Biotech Co., Ltd.'s ROE?
How is the ROE calculated for Oneness Biotech Co., Ltd. (4743.TWO)?
What is the highest ROE for Oneness Biotech Co., Ltd. (4743.TWO)?
What is the 3-year average ROE for Oneness Biotech Co., Ltd. (4743.TWO)?
What is the 5-year average ROE for Oneness Biotech Co., Ltd. (4743.TWO)?
How does the current ROE for Oneness Biotech Co., Ltd. (4743.TWO) compare to its historical average?